About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 979 record(s)
Req # A-2023-00011
Provide all documents from January 1, 2022 to July 12, 2023 on CSA support of space launches and companies in Canada. Including agreements with companies and a (five year) work plan for such launches.Organization: Canadian Space Agency
October 2023
Req # A-2023-00014
Requesting all emails and communications involving a Tweet that was posted 7am Saturday August 19, 2023 concerning a confused tweet that mistook a crater on Earth for one on the moon. It was posted from the Canadian Space Agency Twitter.Organization: Canadian Space Agency
October 2023
Req # A-2015-000352
Records on tackling reducing salt, and sugar, in food products. Internal reviews conducted of mandatory reduction and labelling of salt, sugar in food productsOrganization: Health Canada
October 2023
Req # A-2015-000521
Records and documents in respect of all of Apotex Inc’s submissions for notices of compliance for Apo-tadalafil Pulmonnary Arterial Hypertension (PAH) product, Drug Identification Number (DIN) 02421933.Organization: Health Canada
October 2023
Req # A-2016-000242
All documents between Health Canada and the sponsor regarding section 2.3, 2.5, and 2.7 of the Abbreviated New Drug Submission (ANDS) and Notice of Compliance for RAN-TACROLIMUS.Organization: Health Canada
October 2023
Req # A-2017-001135
All items submitted in the process of obtaining the Drug Identificatoin Number (DIN) - Homeopathic Medicine (HM) for DIN-HM 80022460.Organization: Health Canada
October 2023
Req # A-2018-000655
All scientific studies used and/or referenced by Pest Management Regulatory Agency (PMRA) in determining the proposed re-evaluation decision PRVD2018-13 for Strychnine and its Associated End-use Products (Ground Squirrel Use) dated 29 June 2018.Organization: Health Canada
October 2023
Req # A-2018-001105
Documents constituting the "STATUS DECISION OF CONTROLLED AND NON-CONTROLLED SUBSTANCE(S)" also known as the "Health Canada status decision" issued from January 1, 2012 to November 5, 2018.Organization: Health Canada
October 2023
Req # A-2019-000334
Dymista (Drug Identification Number (DIN) 02432889): - Module 1 submission for Notifiable Changes (NC) for Control Number: 202447 - Module 1 submission for NC for Control Number: 214083.Organization: Health Canada
October 2023
Req # A-2020-000017
In relation to the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017, please provide any Notices of Deficiency (NOD); Notices of Non-Compliance (NON); NOD-Withdrawal or NON-Withdrawal .Organization: Health Canada
October 2023